|
WDR47 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.23430171533801E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.26849641901572E-11 |
| Normal-vs-Stage2 |
1.62409974358013E-10 |
| Normal-vs-Stage3 |
1.85407245112401E-14 |
| Normal-vs-Stage4 |
1.77124981348697E-12 |
| Stage1-vs-Stage2 |
7.594400E-01 |
| Stage1-vs-Stage3 |
1.520040E-01 |
| Stage1-vs-Stage4 |
2.052000E-02 |
| Stage2-vs-Stage3 |
5.021200E-01 |
| Stage2-vs-Stage4 |
1.023390E-01 |
| Stage3-vs-Stage4 |
3.313200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.08730818687764E-12 |
| Normal-vs-AfricanAmerican |
1.96152999999422E-05 |
| Normal-vs-Asian |
1.37769995411929E-09 |
| Caucasian-vs-AfricanAmerican |
2.365000E-01 |
| Caucasian-vs-Asian |
6.760600E-01 |
| AfricanAmerican-vs-Asian |
4.506800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.49547041417009E-13 |
| Normal-vs-Female |
5.69044811271624E-12 |
| Male-vs-Female |
8.244200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.18000112090544E-11 |
| Normal-vs-Age(41-60Yrs) |
6.48037179473704E-13 |
| Normal-vs-Age(61-80Yrs) |
2.51354492775135E-13 |
| Normal-vs-Age(81-100Yrs) |
1.039520E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.854100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.882100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.446400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.040800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.110000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.232000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.111600E-01 |
| Classical-VS-Follicular |
2.060600E-01 |
| Classical-VS-Other |
3.620200E-01 |
| Classical-VS-Normal |
5.60540502902995E-11 |
| Tall-VS-Follicular |
8.654600E-01 |
| Tall-VS-Other |
7.573400E-01 |
| Tall-VS-Normal |
3.43220000198485E-08 |
| Follicular-VS-Other |
6.558400E-01 |
| Follicular-VS-Normal |
1.23629995130159E-11 |
| Other-VS-Normal |
5.636400E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.25897078820481E-12 |
| Normal-vs-N1 |
1.78956849339329E-12 |
| N0-vs-N1 |
3.243400E-01 |
|
|
